MiNK Therapeutics, Inc. (INKT)

MiNK Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.28	4.58	3.37	19.64	38.89	2.69
Cash & Short-Term Investments	14.28	4.58	3.37	19.64	38.89	2.69
Cash Growth	125.67%	35.93%	-82.85%	-49.51%	1345.06%	799.94%
Other Current Assets	0.25	0.41	0.23	0.77	0.75	1.41
Total Current Assets	14.53	4.99	3.6	20.4	39.63	4.1
Net Property, Plant & Equipment	0.43	0.73	0.95	1.07	0.61	0.46
Total Assets	14.96	5.72	4.55	21.47	40.24	4.56
Accounts Payable	3.69	2.73	3.91	5.82	3	3.14
Accrued Expenses	1.26	1.87	5.04	4.24	1.76	1.86
Other Current Liabilities	17.8	7.28	13.61	11.7	11.71	9.22
Total Current Liabilities	13.43	6.96	11.4	12.68	16.47	14.22
Long-Term Debt	5.73	-	-	-	-	43.82
Other Long-Term Liabilities	-	-	0.05	0.11	-	0.38
Total Long-Term Liabilities	5.73	-	0.05	0.11	-	44.21
Total Liabilities	19.16	6.96	11.45	12.79	16.47	58.43
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	141.25	125.23	115.77	110.83	107.35	0.38
Accumulated Other Comprehensive Income	-0.69	-0.63	-0.43	-0.29	-0.63	-1.52
Retained Earnings	-154.07	-144.18	-133.4	-110.94	-82.95	-52.74
Shareholders' Equity	-13.51	-19.59	-18.06	-0.4	23.78	-53.87
Total Liabilities & Equity	14.96	5.72	4.55	21.47	40.24	4.56
Total Debt	5.73	0	0	0	0	43.82
Net Cash (Debt)	8.56	4.58	3.37	19.64	38.89	-41.13
Net Cash Growth	86.93%	35.93%	-82.85%	-49.51%	-	-
Net Cash Per Share	2.09	1.21	0.98	5.83	14.94	-17.06
Book Value	-13.51	-19.59	-18.06	-0.4	23.78	-53.87
Book Value Per Share	-3.31	-5.19	-5.25	-0.12	9.14	-22.35
Tangible Book Value	-13.51	-19.59	-18.06	-0.4	23.78	-53.87
Tangible Book Value Per Share	-3.31	-5.19	-5.25	-0.12	9.14	-22.35

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q